These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2168782

  • 21. Neuropeptide Y receptors in rat brain: autoradiographic localization.
    Martel JC, St-Pierre S, Quirion R.
    Peptides; 1986; 7(1):55-60. PubMed ID: 3012490
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain.
    Widdowson PS, Halaris AE.
    Brain Res; 1991 Jan 25; 539(2):196-202. PubMed ID: 1647239
    [Abstract] [Full Text] [Related]

  • 24. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
    Kelliher M, Fastbom J, Cowburn RF, Bonkale W, Ohm TG, Ravid R, Sorrentino V, O'Neill C.
    Neuroscience; 1999 Jan 25; 92(2):499-513. PubMed ID: 10408600
    [Abstract] [Full Text] [Related]

  • 25. Preferential increases of [125I]NPY1-36 binding in the hippocampal formation produced by the NPY Y2 receptor agonist NPY13-36.
    Hedlund P, Bjelke B, Aguirre JA, Fuxe K.
    Acta Physiol Scand; 1991 Feb 25; 141(2):279-80. PubMed ID: 1646560
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus.
    Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, Unnerstall JR.
    J Neurochem; 1989 Dec 25; 53(6):1772-81. PubMed ID: 2553864
    [Abstract] [Full Text] [Related]

  • 28. Comparison of [125I]Bolton-Hunter neuropeptide Y binding sites in the forebrain of various mammalian species.
    Martel JC, St-Pierre S, Bédard PJ, Quirion R.
    Brain Res; 1987 Sep 01; 419(1-2):403-7. PubMed ID: 2823968
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Characterization of axonally transported [125I]PYY binding sites in rat vagus nerve.
    Corp ES, Smith GP.
    Brain Res; 1991 Jul 05; 553(1):175-9. PubMed ID: 1718539
    [Abstract] [Full Text] [Related]

  • 34. Autoradiographic localization of peptide YY and neuropeptide Y binding sites in the medulla oblongata.
    Leslie RA, McDonald TJ, Robertson HA.
    Peptides; 1988 Jul 05; 9(5):1071-6. PubMed ID: 2854244
    [Abstract] [Full Text] [Related]

  • 35. Peptide YY receptors in the brain.
    Inui A, Oya M, Okita M, Inoue T, Sakatani N, Morioka H, Shii K, Yokono K, Mizuno N, Baba S.
    Biochem Biophys Res Commun; 1988 Jan 15; 150(1):25-32. PubMed ID: 2827668
    [Abstract] [Full Text] [Related]

  • 36. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R.
    Neuropeptides; 2004 Aug 15; 38(4):163-74. PubMed ID: 15337369
    [Abstract] [Full Text] [Related]

  • 37. Solubilization of the neuropeptide Y receptor from rat brain membranes.
    Mannon PJ, Mervin SJ, Taylor IL.
    J Neurochem; 1991 May 15; 56(5):1804-9. PubMed ID: 1849554
    [Abstract] [Full Text] [Related]

  • 38. Differential alterations of ion channel binding sites in temporal and occipital regions of the cerebral cortex in Alzheimer's disease.
    Ikeda M, Dewar D, McCulloch J.
    Brain Res; 1993 Dec 10; 630(1-2):50-6. PubMed ID: 7509712
    [Abstract] [Full Text] [Related]

  • 39. In vivo interaction of neuropeptide Y and peptide YY with sigma receptor sites in the mouse brain.
    Roman FJ, Martin B, Junien JL.
    Eur J Pharmacol; 1993 Oct 05; 242(3):305-7. PubMed ID: 8281995
    [Abstract] [Full Text] [Related]

  • 40. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
    Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R.
    Br J Pharmacol; 2003 Aug 05; 139(7):1360-8. PubMed ID: 12890716
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.